• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子痫前期妇女在未来 15 年内发生心血管结局的风险显著增加。

Preeclamptic Women Are at Significantly Higher Risk of Future Cardiovascular Outcomes Over a 15-Year Period.

机构信息

Rutgers Robert Wood Johnson Medical School, Cardiovascular Institute of New Jersey, New Brunswick, New Jersey.

Department of Ob/Gyn and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.

出版信息

J Womens Health (Larchmt). 2020 Jan;29(1):74-83. doi: 10.1089/jwh.2019.7671. Epub 2019 Aug 16.

DOI:10.1089/jwh.2019.7671
PMID:31414929
Abstract

Preeclampsia (PE) may lead to maternal and infant mortality and severe medical complications. Understanding future short- and long-term cardiovascular (CV) outcomes of PE is important to women's health. A retrospective matched case-control study assessed the risks of CV outcomes over a 15-year period (1999-2013) in pregnant case women, with gravidity and parity of one, diagnosed with PE, compared to pregnant primiparous control women who were not diagnosed with PE. The New Jersey Electronic Birth Certificate (EBC) database and the Myocardial Infarction Data Acquisition System (MIDAS), a database of all hospital admissions in New Jersey with longitudinal follow-up, were used to conduct the analysis. Participants were 18 years and older with demographics consistent with New Jersey, a state with a range of racial and ethnic diversity. Main outcome measures postpregnancy and over this 15-year period were myocardial infarction (MI), stroke, CV death, and all-cause death. Women with PE ( = 6,360) were more likely to suffer MI, stroke, CV death, and all-cause death than controls ( = 325,347). After matching cases to controls for demographics and comorbidities, hazard ratios of PE cases for the outcomes of MI ( adjusted for comorbidities and demographics = 0.0196), CV death (adjusted  = 0.007), and all-cause death (adjusted  = 0.0026) were significantly higher than 1 compared to matched controls. Women with PE had 3.94 (95% CI: 1.25-12.4) times higher hazard for MI, 4.66 (95% CI: 1.52-14.26) times higher hazard of CV death, and 2.32 (95% CI: 1.34-4.02) times higher hazard for all-cause death than matched controls. This 15-year study indicates that women who have PE with their first pregnancy have a significantly higher risk of adverse CV outcomes compared to controls and suggest a heightened and continued CV monitoring after birth for this population of women.

摘要

子痫前期 (PE) 可能导致母婴死亡和严重的医疗并发症。了解 PE 患者未来 15 年内的短期和长期心血管 (CV) 结局对女性健康非常重要。一项回顾性匹配病例对照研究评估了 1999 年至 2013 年间,患有 PE 的初产妇病例组和未被诊断为 PE 的初产妇对照组在 15 年内 CV 结局的风险。该研究使用了新泽西州电子出生证明 (EBC) 数据库和新泽西州所有住院患者的数据库 Myocardial Infarction Data Acquisition System (MIDAS) 进行分析,该数据库具有纵向随访功能。参与者为 18 岁及以上,人口统计学特征与新泽西州一致,该州具有多种种族和民族多样性。主要观察指标为产后和 15 年内的心肌梗死 (MI)、中风、CV 死亡和全因死亡。与对照组 ( = 325,347) 相比,患有 PE 的女性 ( = 6,360) 更易发生 MI、中风、CV 死亡和全因死亡。对病例和对照组进行人口统计学和合并症匹配后,PE 病例组 MI (合并症和人口统计学因素调整后 HR = 0.0196)、CV 死亡 (调整后 HR = 0.007) 和全因死亡 (调整后 HR = 0.0026) 的结局发生风险比 1 显著更高。患有 PE 的女性发生 MI 的风险比对照组高 3.94 倍 (95% CI: 1.25-12.4),发生 CV 死亡的风险比对照组高 4.66 倍 (95% CI: 1.52-14.26),发生全因死亡的风险比对照组高 2.32 倍 (95% CI: 1.34-4.02)。这项为期 15 年的研究表明,初产妇患有 PE 时发生不良 CV 结局的风险明显高于对照组,建议对该人群在产后进行强化和持续的 CV 监测。

相似文献

1
Preeclamptic Women Are at Significantly Higher Risk of Future Cardiovascular Outcomes Over a 15-Year Period.子痫前期妇女在未来 15 年内发生心血管结局的风险显著增加。
J Womens Health (Larchmt). 2020 Jan;29(1):74-83. doi: 10.1089/jwh.2019.7671. Epub 2019 Aug 16.
2
Cardiovascular outcomes after preeclampsia or eclampsia complicated by myocardial infarction or stroke.子痫前期或子痫并发心肌梗死或中风后的心血管结局。
Obstet Gynecol. 2012 Oct;120(4):823-31. doi: 10.1097/AOG.0b013e31826ae78a.
3
Risks of cause-specific mortality in offspring of pregnancies complicated by hypertensive disease of pregnancy.妊娠合并高血压疾病对后代特定病因死亡率的风险。
Am J Obstet Gynecol. 2020 Jan;222(1):75.e1-75.e9. doi: 10.1016/j.ajog.2019.07.024. Epub 2019 Jul 20.
4
Rates of Preeclampsia and Post-preeclamptic Cardiovascular Disease Among US Military Servicewomen: A Retrospective Case-cohort Study.美国军职女性先兆子痫和先兆子痫后心血管疾病的发病率:一项回顾性病例队列研究。
Mil Med. 2024 May 18;189(5-6):1210-1215. doi: 10.1093/milmed/usad300.
5
Incident Coronary Heart Disease After Preeclampsia: Role of Reduced Fetal Growth, Preterm Delivery, and Parity.子痫前期后发生的冠心病:与胎儿生长受限、早产和经产次有关。
J Am Heart Assoc. 2017 Mar 6;6(3):e004158. doi: 10.1161/JAHA.116.004158.
6
Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy.妊娠相关性高血压疾病复发后的长期死亡风险和预期寿命。
Am J Obstet Gynecol. 2018 Jul;219(1):107.e1-107.e6. doi: 10.1016/j.ajog.2018.04.002. Epub 2018 Apr 7.
7
Prognosis after maternal placental events and revascularization: PAMPER study.孕产妇胎盘事件及血管重建后的预后:PAMPER研究
Am J Obstet Gynecol. 2016 Jan;214(1):106.e1-106.e14. doi: 10.1016/j.ajog.2015.08.021. Epub 2015 Aug 14.
8
All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy.妊娠期高血压疾病后的全因死亡率和特定病因死亡率。
Obstet Gynecol. 2016 Aug;128(2):238-244. doi: 10.1097/AOG.0000000000001534.
9
Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa.患有化脓性汗腺炎患者的主要不良心血管事件和全因死亡率风险。
JAMA Dermatol. 2016 Apr;152(4):429-34. doi: 10.1001/jamadermatol.2015.6264.
10
Cardiovascular disease risk is only elevated in hypertensive, formerly preeclamptic women.心血管疾病风险仅在患有高血压的既往先兆子痫女性中升高。
BJOG. 2015 Jul;122(8):1092-100. doi: 10.1111/1471-0528.13057. Epub 2014 Aug 20.

引用本文的文献

1
Hypertensive pregnancy disorder, an under-recognized women specific risk factor for heart failure?妊娠期高血压疾病,一种未得到充分认识的女性特有的心力衰竭危险因素?
Eur J Heart Fail. 2025 Mar;27(3):459-472. doi: 10.1002/ejhf.3520. Epub 2024 Nov 19.
2
Public health and system approach in eliminating disparities in hypertensive disorders and cardiovascular outcomes in non-Hispanic Black women across the pregnancy life course.在整个孕期消除非西班牙裔黑人女性高血压疾病和心血管疾病结局差异的公共卫生与系统方法。
Am Heart J Plus. 2024 Aug 28;46:100445. doi: 10.1016/j.ahjo.2024.100445. eCollection 2024 Oct.
3
The Association Between Hypertensive Disorders in Pregnancy and the Risk of Developing Chronic Hypertension.
妊娠期高血压疾病与患慢性高血压风险之间的关联
Front Cardiovasc Med. 2022 Jul 7;9:897771. doi: 10.3389/fcvm.2022.897771. eCollection 2022.
4
Association between aspirin use during pregnancy and cardiovascular risk factors 2-7 years after delivery: The nuMoM2b Heart Health Study.孕期使用阿司匹林与产后 2-7 年后心血管危险因素的关系:nuMoM2b 心脏健康研究。
Pregnancy Hypertens. 2022 Jun;28:28-34. doi: 10.1016/j.preghy.2022.01.012. Epub 2022 Feb 4.
5
Use of Race, Ethnicity, and National Origin in Studies Assessing Cardiovascular Risk in Women With a History of Hypertensive Disorders of Pregnancy.种族、民族和国籍在评估有妊娠高血压疾病史女性心血管风险研究中的应用。
CJC Open. 2021 Aug 20;3(12 Suppl):S102-S117. doi: 10.1016/j.cjco.2021.08.002. eCollection 2021 Dec.
6
Trends in Prepregnancy Obesity and Association With Adverse Pregnancy Outcomes in the United States, 2013 to 2018.2013年至2018年美国孕前肥胖趋势及其与不良妊娠结局的关联
J Am Heart Assoc. 2021 Sep 7;10(17):e020717. doi: 10.1161/JAHA.120.020717. Epub 2021 Aug 25.
7
Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health Study.血清可替宁与不良心血管结局:nuMoM2b 心脏健康研究的一项横断面二次分析。
Am J Perinatol. 2023 Sep;40(12):1311-1320. doi: 10.1055/a-1580-3155. Epub 2021 Aug 6.
8
Genetic markers for preeclampsia in Peruvian women.秘鲁妇女子痫前期的遗传标志物。
Colomb Med (Cali). 2021 Feb 26;52(1):e2014437. doi: 10.25100/cm.v52i1.4437.
9
Previous preeclampsia and its association with the future development of cardiovascular diseases: a systematic review and meta-analysis.既往子痫前期及其与未来心血管疾病发展的关系:系统评价和荟萃分析。
Clinics (Sao Paulo). 2021 Jan 20;76:e1999. doi: 10.6061/clinics/2021/e1999. eCollection 2021.
10
Maternal Morbidity and Mortality: Are We Getting to the "Heart" of the Matter?孕产妇发病率和死亡率:我们触及问题的“核心”了吗?
J Womens Health (Larchmt). 2021 Feb;30(2):178-186. doi: 10.1089/jwh.2020.8852. Epub 2020 Dec 1.